Premenstrual dysphoric disorder: Prevalence, diagnostic considerations, and controversies

Journal of Psychosomatic Obstetrics and Gynecology

Volumn 27, Issue 4, 2006, Pages 201-210

  Di Giulio, G ^a   Reissing, E D ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Depression; Menstrual cycle; Premenstrual dysphoric disorder; Premenstrual symptoms

Indexed keywords

SEROTONIN;

ANAMNESIS; ARTICLE; COMPARATIVE STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; FUNCTIONAL DISEASE; HUMAN; MAJOR DEPRESSION; MEDICAL LITERATURE; MOOD DISORDER; PATHOGENESIS; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PREVALENCE; WOMEN'S HEALTH;

ADULT; DEPRESSION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MENSTRUAL CYCLE; PREMENSTRUAL SYNDROME; PREVALENCE;

EID: 33845505527     PISSN: 0167482X     EISSN: 17438942     Source Type: Journal    
DOI: 10.1080/01674820600747269     Document Type: Article

References (88)

1. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Simon H. Mind and madness in ancient Greece. Ithaca: Cornell University Press; 1978.
3. Walker AE. The menstrual cycle. New York: Routledge; 1997.
4. Greer G. The female eunuch. London: Paladin; 1971.
5. Frank RT. Hormonal causes of premenstrual tension. Arch Neurol Psychiatry 1931;26:1053-1057.
6. Rapkin A. A review of treatment of premenstrual syndrome & premenstrual dysphoric disorder. Psychoneuroendocrinology 2003;28:39-53.
7. Endicott J, Halbreich U. Clinical significance of premenstrual dysphoric changes. J Clin Psychiatry 1988;49:486-489.
8. Severino SK, Moline ML. Premenstrual syndrome: Identification and management. Drugs 1995;49:71-82.
9. Trickey R. Women, hormones, and the menstrual cycle. Sydney: Allen & Unwin; 1998.
10. Merikangas KR, Foeldenyi M, Angst J. Patterns of menstrual disturbance in the community: Results of the Zurich cohort study. Eur Arch Psychiatry Clin Neurosci 1993;243:23-32.
11. Severino SK, Moline ML. Premenstrual syndrome. Obstet Gynecol Clin North Am 1990;17:889-903.
12. Hurt SW, Schnurr PP, Severino SK, Freeman EW, Gise LH, Rivera-Tovar A, Steege JF. Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints. Am J Psychiatry 1992;149:525-530.
13. Pearlstein T, Stone AB. Premenstrual syndrome. Psychiatr Clin North Am 1998;21:577-589.
14. Wittchen HU, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 2002;32:119-132.
15. Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003;28:1-23.
16. Dimmock PW, Wyatt KM, Jones PW, O'Brien PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000;356:1131-1136.
17. Rapkin AJ, Edelmuth E, Chang LC, Reading AE, McGuire MT, Su TP. Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol 1987;70:533-537.
18. Yonkers KA, Gullion C, Williams A, Novak K, Rush JA. Paroxetine as a treatment for premenstrual dysphoric disorder. J Clin Psychopharmacol 1996;16:3-8.
19. Steinberg S, Annable L, Young SN, Liyanage N. A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria. Biol Psychiatry 1999;45:313-320.
20. Brzezinski AA, Wurtman JJ, Wurtman RJ, Gleason R, Greenfield J, Nader T. d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves mood of women with premenstrual depression. Obstet Gynecol 1990;76:296-301.
21. Parry BL, Berga SL, Kripke DF, Klauber MR, Laughlin GA, Yen SS, Gillin JC. Altered waveform of plasma nocturnal melatonin serotonin in premenstrual depression. Arch Gen Psychiatry 1990;47:1139-1146.
22. Michener W, Rozin P, Freeman E, Gale L. The role of low progesterone and tension as triggers of perimenstrual chocolate and sweets craving: Some negative experimental evidence. Physiol Behav 1999;67:417-420.
23. Smith SS. Pre-menstrual steroids. Cell Mol Life Sci 2001;58:1263-1275.
24. Watson NR, Studd JW, Savvas M, Baber RJ. The long-term effects of estradiol implant therapy for the treatment of premenstrual syndrome. Gynecol Endocrinol 1990;4:99-107.
25. Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: Clinical implications. Ann Intern Med 1998;129:229-240.
26. Halbreich U. The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology 2003;28:55-99.
27. Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 1995;37:434-441.
28. McEwen BS, Alves SE, Bulloch K. Ovarian steroids and the brain: Implications for cognition and aging. Neurology 1997;48:S8-S15.
29. Halbreich U, Endicott J, Goldstein S, Nee J. Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand 1986;74:576-586.
30. Redei E, Freedman ED. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms. Psychoneuroendocrinology 1995;20:259-267.
31. Rubinow DR, Hoban MC, Grover GN, Galloway DS, Roy-Byrne P, Andersen R, Merriam GR. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol 1988;158:5-11.
32. Facchinetti F, Martignoni E, Petraglia F, Sances MG, Nappi G, Genazzani AR. Premenstrual fall of plasma beta-endorphin in patients with premenstrual syndrome. Fertil Steril 1987;47:570-573.
33. Giannini AJ, Martin DM, Turner CE. Beta-endorphin decline in late luteal phase dysphoric disorder. Int J Psychiatry Med 1990;20:279-284.
34. Halbreich U, Endicott J. Possible involvement of endorphin withdrawal or imbalance in specific premenstrual syndromes and postpartum depression. Med Hypotheses 1981;7:1045-1058.
35. Chuong CJ, Coulam CB, Kao PC, Bergstralh EJ, Go VL. Neuropeptide levels in premenstrual syndrome. Fertil Steril 1985;44:760-765.
36. Blake F. Cognitive therapy for premenstrual syndrome. Cognitive and Behavioral Practice 1995;2:167-185.
37. Fontana AM, Palfai TG. Psychosocial factors in premenstrual dysphoria: Stressors, appraisal, and coping processes. J Psychosom Res 1994;38:557-567.
38. Fontaine K. Optimism, social support, and premenstrual dysphoria. J Clin Psychol 1997;53:243-247.
39. Blake F, Salkovskis P, Gath D, Day A, Garrod A. Cognitive therapy for premenstrual syndrome: A controlled trial. J Psychosom Res 1998;45:307-318.
40. Christensen AP, Oei TP. The efficacy of cognitive behavior therapy in treating premenstrual dysphoric changes. J Affect Disord 1995;33:57-63.
41. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders (DSM-III-R). 3rd ed. Washington, DC: American Psychiatric Association; 1987.
42. Severino SK. Late luteal phase dysphoric disorder: A scientific puzzle. Med Hypotheses 1993;41:229-234.
43. Caplan PJ. They say you're crazy: How the world's most powerful psychiatrists decide whose normal. New York: Addison-Wesley; 1995.
44. Endicott J, Amsterdam J, Eriksson E, Frank E, Freeman E, Hirschfeld R, Ling F, Parry B, Pearlstein T, Rosenbaum J, Rubinow D, Schmidt P, Severino S, Steiner M, Stewart DE, Thys-Jacobs S. Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gend Based Med 1999;8:663-679.
45. Landén M, Eriksson E. How does premenstrual dysphoric disorder relate to depression and anxiety disorders? Depress Anxiety 2003;17:122-129.
46. Warner P, Bancroft J. Factors related to self-reporting of the pre-menstrual syndrome. Br J Psychiatry 1990;157:249-260.
47. Rapkin AJ, Chang LC, Reading AE. Comparison of retrospective and prospective assessment of premenstrual symptoms. Psychol Rep 1988;62:55-60.
48. Morse CA, Dennerstein L, Varnavides K, Burrows GD. Menstrual cycle symptoms: Comparison of a non-clinical sample with a patient group. J Affect Disord 1988;14:41-50.
49. Gallant SJ, Hamilton JA. On a premenstrual psychiatric diagnosis: What's in a name? Prof Psychol: Res Pract 1988;19:271-278.
50. Hamilton JA, Alagna SW. Toward a clinical research perspective. In: Gise LH, Kase NG, Berkowitz RL, editors. The premenstrual syndromes. New York: Churchill-Livingston; 1988. pp 35-46.
51. Smith SS. Pre-menstrual steroids. Cell Mol Life Sci 2001;58:1263-1275.
52. Spitzer RL, Severino SK, Williams JB, Parry BL. Late luteal phase dysphoric disorder and DSM-III-R. Am J Psychiatry 1989;146:892-897.
53. Brooks-Gunn J. Differentiating premenstrual symptoms and syndromes. Psychosom Med 1986;48:385-387.
54. Barnhart KF, Freeman EW, Sondheimer SJ. A clinician's guide to the premenstrual syndrome. Med Clin North Am 1995;79:1457-1472.
55. Severino SK. Letters to the editor. Am J Psychiatry 1988;145:132-133.
56. Yonkers KA. The association between premenstrual dysphoric disorder and other mood disorders. J Clin Psychiatry 1997;58:19-25.
57. Endicott J. Differential diagnoses and comorbidity. In: Gold JH, Severino SK, editors. Premenstrual dysphorias: Myths and realities. Washington, DC: American Psychiatric Press; 1994. pp 3-17.
58. Chuong CJ, Burgos DM. Medical history in women with premenstrual syndrome. J Psychosom Obstet Gynaecol 1995;16:21-27.
59. Warner P, Bancroft J, Dixson A, Hampson M. The relationship between perimenstrual depressive mood and depressive illness. J Affect Disord 1991;23:9-23.
60. Bhatia SB, Bhatia SK. Diagnosis and treatment of premenstrual dysphoric disorder. Am Fam Physician 2003;66:1239-1248.
61. Angst J, Sellaro R, Stolar M, Merikangas KR, Endicott J. The epidemiology of premenstrual symptoms. Acta Psychiatr Scand 2001;104:110-116.
62. Glick R, Harrison W, Endicott J, McGrath P, Quitkin FM. Treatment of premenstrual dysphoric symptoms in depressed women. J Am Med Wom Assoc 1991;46:182-185.
63. Eriksson J, Lisjō P, Sunblad C, Andersson K, Andersch B, Modigh K. Effect of clomipramine in the premenstrual syndrome. Acta Psychiatr Scand 1990;81:87-88.
64. Wikander I, Sundblad C, Andersch B, Dagnell I, Zyberstein D, Bengtsson F, Eriksson E. Citalopram in premenstrual dysphoria: Is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J Clin Psychopharmacol 1998;18:390-398.
65. Freeman EW, Rickels K, Sondheimer SJ, Polansky M. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: A randomized controlled trial. Arch Gen Psychiatry 1999;56:932-939.
66. Kaspi SP, Otto MW, Pollack MH, Eppinger S, Rosenbaum JF. Premenstrual exacerbation of symptoms in women with panic disorder. J Anxiety Disord 1994;8:131-138.
67. Hendrick V, Altshuler LL, Burt VK. Course of psychiatric disorders across the menstrual cycle. Harv Rev Psychiatry 1996;4:200-207.
68. Dickerson LM, Mazyck PJ, Hunter MH. Premenstrual syndrome. Am Fam Physician 2003;67:1743-1752.
69. Anderson M, Severino SK, Hurt SW, Williams NA. Premenstrual syndrome research: Using the NIMH guidelines. J Clin Psychiatry 1988;49:484-486.
70. Fava M. Comorbid anxiety and depression among patients with late luteal phase dysphoric disorder. J Anxiety Disord 1992;6:325-335.
71. Freeman EW. Premenstrual syndrome and premenstrual dysphoric disorder: Definitions and diagnosis. Psychoneuroendocrinology 2003;28:25-37.
72. Chawla A, Swindle R, Long S, Kennedy S, Sternfield B. Premenstrual dysphoric disorder: Is there an economic burden of illness? Med Care 2002;40:1101-1112.
73. Hellman J, Georgiev N. The premenstrual syndrome and the absence from work due to illness. J Psychosom Obstet Gynecol 1987;6:111-119.
74. Hylan TR, Sundell K, Judge R. The impact of premenstrual symptomology on functioning and treatment-seeking behaviour: Experience from the United States, United Kingdom and France. J Womens Health Gend Based Med 1999;8:1043-1052.
75. Kuan AJ, Carter DM, Ott FJ. Distress levels in patients with premenstrual dysphoric disorder. Can J Psychiatry 2002;47:888-889.
76. Campbell EM, Peterkin D, O'Grady K, Sanson-Fisher R. Premenstrual symptoms in general practice patients: Prevalence and treatment. J Reprod Med 1997;42:637-646
77. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV, III, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994;272:1749-1756.
78. Pearlstein TP, Stone AB, Lund SA, Scheft H, Zlotnick C, Brown WA. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. J Clin Psychopharmacol 1997;17:261-266.
79. Hamilton JA, Gallant SJ. Debate on late luteal phase dysphoric disorder. Am J Psychiatry 1990;147:1106-1107.
80. Caplan PJ, McCurdy-Myers J, Gans M. Should premenstrual syndrome be called a psychiatric abnormality? Feminist Psychol 1992;2:27-44.
81. Freeman EW. Premenstrual syndrome and quality of life: Does treatment make life better? Arch Womens Ment Health 2001;3(2):7.
82. Offman A, Kleinplatz PJ. Does PMDD belong in the DSM? Challenging the medicalizaton of women's bodies. Can J Hum Sex 2004;13:17-28.
83. Nash HC, Chrisler JC. Is a little (psychiatric) knowledge a dangerous thing? Psychol Wom Q 1997;21:315-322.
84. Fausto-Sterling A. Myths of gender: Biological theories about women and men. New York: Basic Books; 1985.
85. Anson O. Exploring the bio-psycho-social approach to premenstrual experience. Soc Sci Med 1999;49(1):67-80.
86. Woods NF, Mitchell ES, Lentz MJ. Social pathways to premenstrual symptoms. Res Nurs Health 1995;18:225-237.
87. Whitehead WE, Busch CM, Heller BR, Costa JR. Social learning influences on menstrual symptoms and illness behaviour. Health Psychol 1986;5:13-23.
88. Taylor D, Woods NF, Lentz M, Mitchell ES, Lee K. Perimenstrual negative affect: Development and testing of an explanatory model. In: Taylor D, Woods NF, editors. Menstruation: Health and illness. Washington, DC: Hemisphere; 1991. pp 103-118.